Evidence-led guide Clinical review pending · 10 October 2026

An Australian evidence guide

Creatine for women:
the plain-English guide.

You have questions.
Start with the short answer.
Then see what sits behind it.

Find your question

Good questions. Clear answers.

01—08

Short answers need context. Open any question to read the findings, sources and limitations.

The things you’ve heard

What does the
research actually say?

“It makes you bulky.” “It’s only for men.” Creatine comes with a lot of baggage. We look at six common claims and show you where the evidence stands.

Take a closer look at the myths

How to use this guide

What sits behind a short answer?

Every answer comes with a route back to the research. We show who took part, what was measured and what a study cannot tell us. Checking a source is one step in our process. It does not replace review by a qualified health professional.

01

Read the answer.

A starting point in plain English.

02

Check the context.

Who was studied, and for how long?

03

Follow the source.

Open the paper. Read its limits.

Read our editorial method ↗

Open the research

What evidence are we drawing on?

24 source records in the library · Checked 10 Oct 2026

These cards introduce four sources from the full evidence library. Each separates the finding from the limits, and links to the published paper. A study involving men is labelled as such. Clinical review is still pending, so these pages remain a working draft for review.

Randomised trial2023

Chilibeck et al., 2023

No added bone-density or measured strength benefit; selected bone-geometry measures and walking time favoured creatine.

Who
237 postmenopausal women, mean age 59, randomised
Dose
0.14 g/kg/day
Duration
2 years
Limits
Both groups exercised. Lean-mass benefit appeared in a valid-completers subanalysis. Secondary bone geometry findings are not proof of fewer fractures.
Read the published paper (opens in a new tab)
Systematic review2020

de Guingand et al., 2020

The review found no serious adverse events attributed to creatine in the included female studies.

Who
951 female participants across 29 studies monitoring adverse outcomes
Dose
Varied across studies
Duration
Varied across studies
Limits
Safety reporting was inconsistent. This is not a guarantee for every person, dose or medical situation.
Read the published paper (opens in a new tab)
Randomised trial2025

Lak et al., 2025

No significant difference in hair outcomes or DHT between creatine and placebo.

Who
Resistance-trained men aged 18 to 40; 38 completers, 37 with hair assessments
Dose
5 g/day
Duration
12 weeks
Limits
Men only, small sample and 12 weeks. This does not establish long-term effects in women.
Read the published paper (opens in a new tab)
Meta-analysis2026

Postmenopausal meta-analysis, 2026

Small lean-mass and leg-press strength benefits were found overall; bone density was unchanged.

Who
608 women randomised in seven trials; lean mass pooled 338 women, leg-press strength 111
Dose
Varied; benefits were seen in trials using at least 5 g/day with resistance training
Duration
12 to 104 weeks
Limits
Mostly some risk-of-bias concerns; not prospectively registered. Dose and training varied together. Lean mass includes water, and its prediction interval included no effect.
Read the published paper (opens in a new tab)
Explore all 24 source records ↗

This guide is about understanding the evidence.

We don’t rank or sell products here. If we introduce our own product in future, every mention will be clearly labelled as ours.